#20;(R)-2-[1-[(R)-2-[(1-((R)-2-(1-N-TERT.-BUTOXYCARBONYL-AMINO)-ETHYL-5-METHYLOXAZOLE-4-CARBONYL)-AMINO]-ISOBUTYLTHIAZOLE-4-CARBONYL]-AMINO]-ETHYLTHIAZOLE-4-CA
Compound with spectra: 1 NMR
![#20;(R)-2-[1-[(R)-2-[(1-((R)-2-(1-N-TERT.-BUTOXYCARBONYL-AMINO)-ETHYL-5-METHYLOXAZOLE-4-CARBONYL)-AMINO]-ISOBUTYLTHIAZOLE-4-CARBONYL]-AMINO]-ETHYLTHIAZOLE-4-CA](/api/compound/ETQRhkhUd5Z.png?ph=true&h=300&w=458 "#20;(R)-2-[1-[(R)-2-[(1-((R)-2-(1-N-TERT.-BUTOXYCARBONYL-AMINO)-ETHYL-5-METHYLOXAZOLE-4-CARBONYL)-AMINO]-ISOBUTYLTHIAZOLE-4-CARBONYL]-AMINO]-ETHYLTHIAZOLE-4-CA")
| SpectraBase Compound ID | ETQRhkhUd5Z |
|---|---|
| InChI | InChI=1S/C28H38N6O7S2/c1-10-39-26(37)18-12-42-24(32-18)15(5)29-21(35)17-11-43-25(31-17)19(13(2)3)33-22(36)20-16(6)40-23(34-20)14(4)30-27(38)41-28(7,8)9/h11-15,19H,10H2,1-9H3,(H,29,35)(H,30,38)(H,33,36)/t14-,15+,19+/m0/s1 |
| InChIKey | CYGBRXGBRMUCEF-QMTMVMCOSA-N |
| Mol Weight | 634.8 g/mol |
| Molecular Formula | C28H38N6O7S2 |
| Exact Mass | 634.22434 g/mol |
| Enantiomer InChIKey | CYGBRXGBRMUCEF-VCBZYWHSSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
VENTURAMIDE_B;CYCLO-D-ALLO-THR-TZL-D-VAL-TZL-D-ALA-MOZL
TENUECYClAMIDE_D;MAJOR_SULFOXIDE_ISOMER
Tenuecyclamide D
ULITHIACYClAMIDE_E
#4A;METHYL-2-[(1S)-1-[(TERT.-BUTOXYCARBONYL)-AMINO]-ETHYL]-5-[(1S)-[[(9H-FLUOREN-9-YLMETHOXY)-CARBONYL]-AMINO]-METHYL]-1,3-OXAZOLE-4-CARBOXYLATE
Diethyl 3-[(R)-methoxy(trifluoromethyl)phenylacetoxy]pyrrolidine-1,2-dicarboxylate
(8R)-13.alpha.-Hydroxy-15,16-dinor-pimaran-14-one
(8S)-13.beta.-Hydroxy-15,16-dinor-pimaran-14-one
(8S)-13.alpha.-Hydroxy-15,16-dinor-pimaran-14-one
3-(3-methoxyphenyl)-2-[(E)-2-(3-methylphenyl)ethenyl]-4(3H)-quinazolinone
| Title | Journal or Book | Year |
|---|---|---|
| Total Synthesis of Dendroamide A, a Novel Cyclic Peptide That Reverses Multiple Drug Resistance | The Journal of Organic Chemistry | 2001 |